Athira Pharma Inc
For the period ended May 29, 2025. Filed Apr 14, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 29, 2025 · Filed Apr 14, 2025
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT SUMMARY
Proxy Statement
Summary
Meeting Date:
May 29, 2025
Meeting Time:
8:00 a.m., Pacific Time
Meeting Location:
The Annual Meeting will be conducted virtually via live audio webcast. You will be able to attend the Annual Meeting virtually by visiting www.virtualshareholder meeting.com/ ATHA2025, where you will be able to listen to the meeting live, submit questions and vote online during the meeting.
VOTING MATTERS
| Proposal · BoardRecommendation · PageReference | |||
|---|---|---|---|
| 1 | To elect three Class II directors of the Company, each to serve for a term of three years and until his respective successor is elected and qualified, or until his earlier death, resignation or removal. | “FOR” the election of each Class II director nominee named | 23 |
| 2 | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2025. | “FOR” the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025 | 24 |
| 3 | To approve proposed amendments to our amended and restated certificate of incorporation to effect a reverse stock split and reduce the total number of authorized shares of common stock. | “FOR” the approval of proposed amendments to our amended and restated certificate of incorporation to effect a reverse stock split and reduce the total number of authorized shares of common stock | 27 |
| 4 | To vote on any other matters that may properly come before the Annual Meeting. | — | — |
The Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability”) containing instructions on how to access this proxy statement, the accompanying notice of annual meeting and form of proxy, and our annual report, is first being sent or given on or about April 14, 2025 to all stockholders of record as of April 4, 2025.
| Athira Pharma, Inc. | 1 | 2025 Proxy Statement |
|---|
PROXY STATEMENT
To be Held at 8:00 a.m., Pacific Time, on May 29, 2025
The board of directors of Athira Pharma, Inc., a Delaware corporation (“we,” “us,” “our,” the “Company” or “Athira”), is soliciting proxies to be used at our 2025 annual meeting of stockholders (together with any postponement, adjournment or continuation thereof, the “Annual Meeting”). The Annual Meeting will be held on May 29, 2025, at 8:00 a.m., Pacific Time. The Annual Meeting will be conducted virtually via live audio webcast. You will be able to attend the Annual Meeting virtually by visiting www.virtualshareholdermeeting.com/ATHA2025, where you will be able to listen to the meeting live, submit questions and vote online during the meeting.
The Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability”), containing instructions on how to access this proxy statement, the accompanying notice of annual meeting and form of proxy, and our annual report, is first being sent or given on or about April 14, 2025 to all stockholders of record as of April 4, 2025. The proxy materials and our annual report can be accessed as of April 14, 2025 by visiting www.proxyvote.com. If you receive a Notice of Internet Availability, then you will not receive a printed copy of the proxy materials or our annual report in the mail unless you specifically request these materials. Instructions for requesting a printed copy of the proxy materials and our annual report are set forth in the Notice of Internet Availability.
The information provided in the “question and answer” format below is for your convenience only and is merely a summary of the information contained in this proxy statement. You should read this entire proxy statement carefully.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.